The difference (adenomas with low-grade dysplasia vs. adenomas with high-grade dysplasia and adenomas with low-grade dysplasia vs. carcinomas) was statistically significant for MLH1-associated tumors. This evidence concerns the gene MLH1 and carcinoma.